The NCI Cancer Research Data Commons Proteomic Data Commons (PDC) has new data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and the International Cancer Proteogenome Consortium (ICPC) - Taiwan Lung Adenocarcinoma (LUAD) studies.

Led by CPTAC’s Drs. Michael Gilettte, D. R. Mani, Steven Carr, and Ling Ding, the study used a suite of molecular techniques to discover novel and clinically relevant biology across subtypes and stages. This data set uniquely includes an almost equal number of tumors from smoking- and never-smoking patients.

The release contains open-access proteomic data for 213 lung cancer cases obtained from the following:

• Proteomic, phosphoproteomic, and acetylomics methods
• Genomic and transcriptomics

Explore the LUAD data through the PDC.